Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P57
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20257.41%
202444.09%
2023270.65%
2022-176.64%
20212481.25%
2020-96.42%
2019192.85%
201886.03%
2017-21.74%
20168.28%